Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsIONTOPHORESIS, TOPICALGeneric

LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE

EPINEPHRINE; LIDOCAINE HYDROCHLORIDE

Standard Dose
0.01MG/ML;2%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE is listed in Drugs@FDA under application 021486 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient EPINEPHRINE; LIDOCAINE HYDROCHLORIDE Form and strength SOLUTION;IONTOPHORESIS, TOPICAL - 0.01MG/ML;2% Sponsor EMPI Submission history Latest submission status date: 2004-10-26 00:00:00.

Structured Monograph

Clinical summary

Approval overview LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE is listed in Drugs@FDA under application 021486 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient EPINEPHRINE; LIDOCAINE HYDROCHLORIDE Form and strength SOLUTION;IONTOPHORESIS, TOPICAL - 0.01MG/ML;2% Sponsor EMPI Submission history Latest submission status date: 2004-10-26 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE; LIDOCAINE HYDROCHLORIDE) | Drug Monograph | MedicHelpline